Screener
Orchestra BioMed Holdings, Inc. OBIO Q1 2026 earnings
Reported May 12, 2026 · Before market open
Revenue$110.0KMiss by $808.7K
EPS-$0.33Beat by $0.07
Revenue estimate$918.7K
EPS estimate-$0.40
Next report
Nov 9, 2026 (in 2 months)Revenue estimate$128.0K
EPS estimate-$0.40
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Orchestra BioMed Holdings, Inc. report Q1 2026 earnings?
- Orchestra BioMed Holdings, Inc. (OBIO) reported Q1 2026 earnings on May 12, 2026 before market open.
- What were Orchestra BioMed Holdings, Inc.'s Q1 2026 revenue and EPS?
- Orchestra BioMed Holdings, Inc. reported revenue of $110.0K and eps of $-0.33 for Q1 2026.
- Did Orchestra BioMed Holdings, Inc. beat estimates in Q1 2026?
- Revenue missed the consensus estimate of $918.7K by $808.7K. EPS beat the consensus estimate of $-0.40 by $0.07.
- How did Orchestra BioMed Holdings, Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 56.5% from $253.0K a year earlier and eps grew 23.3% from $-0.43.
- Where can I find Orchestra BioMed Holdings, Inc.'s Q1 2026 SEC filings?
- You can read the 10-Q periodic report (0001104659-26-059382) directly on SEC EDGAR. The filing index links above go to sec.gov.
